Sotera Health (SHC) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Sotera Health Company  (NASDAQ: SHC)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Select the Financial Report: Select the Period:


Description of Sotera Health's Business Segments


Sotera Health Company provides a comprehensive suite of segments, products, and services specifically targeting the medical and healthcare sectors, emphasizing safety, efficiency, and regulatory compliance. The following extensive overview delves deeply into each segment, product, and service offered by the company.

Segments

1. Sterilization:
- The sterilization segment plays a critical role in healthcare microbiological safety. Sotera Health specializes in a variety of sterilization methods, including ethylene oxide (EO) sterilization and gamma irradiation. These processes are essential for sanitizing medical instruments, surgical devices, and other healthcare-related equipment while ensuring that they remain free from harmful pathogens.

2. Radiation Technologies:
- This segment encompasses advanced radiation technologies such as gamma irradiation and electron beam sterilization. These methods are not only invaluable in the sterilization of medical products but also have applications in industrial settings where materials require thorough microbial reduction. The integration of these technologies helps facilities achieve high standards of safety and compliance.

3. Packaging Solutions:
- The packaging solutions segment provides a range of services aimed at developing packaging that maintains the sterility and integrity of medical and food products. This includes the use of specialized materials such as plastics and foils designed to withstand sterilization processes while preventing contamination during storage and transport.

4. Product Solutions:
- The product solutions segment focuses on enhancing the quality and safety of medical devices, pharmaceuticals, and consumables through meticulous design, development, and rigorous testing. This segment ensures that products meet high safety and efficacy standards, facilitating seamless regulatory approval.

Products

1. SteriLink:
- SteriLink is an integrated service solution that offers healthcare providers tools to manage their sterilization processes effectively. It features advanced tracking and reporting software, complemented by state-of-the-art sensors that monitor and confirm the effectiveness of sterilization methods applied to various medical instruments and devices.

2. AsepticSure:
- AsepticSure employs innovative fogging technology to sanitize environments within healthcare facilities. The system generates a fine mist of disinfectant that penetrates surfaces, providing a comprehensive disinfection solution that addresses airborne pathogens and surfaces alike, thereby enhancing infection control measures.

3. Rapiseal:
- Rapiseal is an innovative sterilization pouch designed to safeguard medical devices from contamination during the sterilization process and while stored. Available in multiple sizes and made from assorted materials, Rapiseal ensures that devices remain sterile until usage, thereby minimizing the risk of infection.

4. QAmped:
- QAmped represents a suite of validation, testing, and certification services that include microbiological testing, packaging integrity testing, and cleanroom validations. This suite assists businesses in ensuring compliance with stringent industry standards and regulations, thus bolstering the reliability of their products.

Services

1. Sterilization Validation:
- This service is centered around the thorough testing and validation of sterilization techniques. By exploring the efficacy of different methods, Sotera Health ensures that end-users can trust that medical products are safe and effective.

2. Gamma Irradiation:
- Sotera Health offers specialized gamma irradiation services designed to eradicate harmful microorganisms and deactivate viruses on medical devices, ensuring they are safe for patient use. This service is pivotal in various medical applications where device sterility is paramount.

3. Sterility Assurance:
- The sterility assurance service ensures that all sterilization processes adherently comply with industry guidelines. This service mitigates the risk of contamination by validating procedures to affirm that products meet all necessary regulatory requirements for safety.

4. Radiation Sterilization:
- Utilizing radiation as a means for sterilizing medical devices, packaging, and pharmaceutical products, this service ensures that all harmful pathogens are effectively eliminated, making products safe for use in healthcare environments.

Conclusion

Sotera Health Company stands at the intersection of healthcare safety and efficiency, providing an extensive portfolio designed to mitigate infection risks while promoting hygiene. With a strong emphasis on technological advancement and compliance, the company integrates high-energy, low-temperature sterilization methods with regulatory consulting and validation services. The proprietary products and technology solutions offered empower healthcare providers to maintain high standards in preventing the spread of infectious diseases, ultimately enhancing patient outcomes.


Composition of Sotera Health Company Revenues by Segments

 
Service    161.78 % of total Revenue
Product    25.36 % of total Revenue
Sterigenics    123.75 % of total Revenue
Nordion    28.36 % of total Revenue
Nelson Labs    35.02 % of total Revenue
Intersegment Eliminations    9.18 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Service 519.93 161.78 %
Product 81.49 25.36 %
Sterigenics 397.71 123.75 %
Nordion 91.16 28.36 %
Nelson Labs 112.56 35.02 %
Intersegment Eliminations 29.50 9.18 %
Total 321.38 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Service - -
Product - -
Sterigenics 104.12 % 113.67 %
Nordion 114.84 % 117 %
Nelson Labs 97.22 % 116.87 %
Intersegment Eliminations - -
Total 9.45 % 15.16 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Sterigenics 214.54 53.94 %
Nordion 51.69 56.7 %
Nelson Labs 34.16 30.35 %
Segment Reporting, Reconciling Item, Corporate Nonsegment 24.32 -
Total 53.64 16.69 %




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Sterigenics - -
Nordion - -
Nelson Labs - -
Segment Reporting, Reconciling Item, Corporate Nonsegment - -
Total 573.74 % 101.75 %




Annual Report on Sotera Health Company Divisions, Sales by Country

 
Sterigenics   Sterigenics Segment contribution to total sales 64.96 % of total Revenue
Nordion   Nordion Segment contribution to total sales 16.12 % of total Revenue
Nelson Labs   Nelson Labs Segment contribution to total sales 18.93 % of total Revenue
Point in time   Point in time Segment contribution to total sales 80.67 % of total Revenue
Over time   Over time Segment contribution to total sales 19.34 % of total Revenue
Sterigenics Point in time   Sterigenics Point in time Segment contribution to total sales 64.96 % of total Revenue
Nordion Point in time   Nordion Point in time Segment contribution to total sales 15.71 % of total Revenue
Nordion Over time   Nordion Over time Segment contribution to total sales 0.41 % of total Revenue
Nelson Labs Over time   Nelson Labs Over time Segment contribution to total sales 18.93 % of total Revenue
Intersegment   Intersegment Segment contribution to total sales -2.23 % of total Revenue
United States   United States Segment contribution to total sales 54.11 % of total Revenue
Canada   Canada Segment contribution to total sales 19.08 % of total Revenue
Europe   Europe Segment contribution to total sales 19.95 % of total Revenue
Other   Other Segment contribution to total sales 6.87 % of total Revenue
Asia   Asia Segment contribution to total sales 0 % of total Revenue
Latin America   Latin America Segment contribution to total sales 0 % of total Revenue


Twelve months ended 2025
SHC s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Sterigenics 755.78 64.96 %
Nordion 187.62 16.12 %
Nelson Labs 220.22 18.93 %
Total 1,163.53 100 %
Point in time 938.60 80.67 %
Over time 225.02 19.34 %
Sterigenics Point in time 755.78 64.96 %
Nordion Point in time 182.82 15.71 %
Nordion Over time 4.80 0.41 %
Nelson Labs Over time 220.22 18.93 %
Intersegment -25.90 -2.23 %
United States 629.54 54.11 %
Canada 221.95 19.08 %
Europe 232.18 19.95 %
Other 79.95 6.87 %
Asia 0.00 0 %
Latin America 0.00 0 %


Twelve months ended 2025
SHC s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total 77.95 6.7 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Sterigenics 8.3 % -
Nordion 8.23 % -
Nelson Labs -3.93 % -
Total 5.75 % 75.57 %
Point in time 7.99 % -
Over time -2.72 % -
Sterigenics Point in time 8.3 % -
Nordion Point in time 6.74 % -
Nordion Over time 131.69 % -
Nelson Labs Over time -3.93 % -
Intersegment - -
United States 2.09 % -
Canada 6.25 % -
Europe 18.45 % -
Other 1.38 % -
Asia 0 % -
Latin America 0 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.